BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 3004753)

  • 1. Binding characteristics of [3H]dihydroalprenolol to beta-adrenergic receptors of rat brain: comparison with those of rat heart treated with neuraminidase.
    Tsuchihashi H; Sasaki M; Nagatomo T
    Chem Pharm Bull (Tokyo); 1985 Sep; 33(9):3972-6. PubMed ID: 3004753
    [No Abstract]   [Full Text] [Related]  

  • 2. Binding characteristics of 3H-dihydroalprenolol to beta-adrenoceptors of rat heart treated with neuraminidase.
    Nagatomo T; Sasaki M; Tsuchihashi H; Imai S
    Jpn J Pharmacol; 1983 Aug; 33(4):851-7. PubMed ID: 6314011
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [3H]dihydroalprenolol binding in the rat brainstem.
    Stone EA; U'Prichard DC
    Eur J Pharmacol; 1981 Oct; 75(2-3):159-61. PubMed ID: 6119217
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of phospholipids on the binding of [3H]dihydroalprenolol to the beta-adrenergic receptor of rabbit heart membranes.
    Thang NX; Borsodi A; Wollemann M
    Biochem Pharmacol; 1980 Oct; 29(20):2791-7. PubMed ID: 6254538
    [No Abstract]   [Full Text] [Related]  

  • 5. [3H]Dihydroalprenolol binding sites in rat myocardium: relationship between a single binding site population and the concentration of radioligand.
    Winek R; Bhalla R
    Biochem Biophys Res Commun; 1979 Nov; 91(1):200-6. PubMed ID: 229841
    [No Abstract]   [Full Text] [Related]  

  • 6. Binding characteristics of 3H-dihydroalprenolol to beta-adrenergic receptors of rat brain: influence of lectins.
    Tsuchihashi H; Nagatomo T
    Jpn J Pharmacol; 1985 Jun; 38(2):121-5. PubMed ID: 2993717
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of 3H-dihydroalprenolol binding to beta-adrenergic receptors of rat brain: two binding sites of racemic propranolol in displacement experiments.
    Tsuchihashi H; Nagatomo T
    Chem Pharm Bull (Tokyo); 1987 Jul; 35(7):2979-84. PubMed ID: 2824078
    [No Abstract]   [Full Text] [Related]  

  • 8. Aliphatic alcohols and the inhibition by thiol chelating agents of the binding of [3H[ dihydroalprenolol to myocardial beta-adrenoceptors.
    Moustafa E; Wong M
    Gen Pharmacol; 1981; 12(6):439-44. PubMed ID: 6273256
    [No Abstract]   [Full Text] [Related]  

  • 9. Temperature dependence of [3H]dihydroalprenolol binding in rat myocardium.
    Winek R; Bhalla R
    Eur J Pharmacol; 1982 Jan; 77(2-3):89-94. PubMed ID: 6277664
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serotonin depletion unmasks serotonergic component of [3H]dihydroalprenolol binding in rat brain.
    Stockmeier CA; Kellar KJ
    Mol Pharmacol; 1989 Dec; 36(6):903-11. PubMed ID: 2557537
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Binding characteristics of 3H-dihydroalprenolol to beta-adrenergic receptors of rat brain: influence of exo- and endo-glycosidases and glycopeptidase.
    Tsuchihashi H; Nagatomo T
    Jpn J Pharmacol; 1985 Aug; 38(4):403-9. PubMed ID: 2999487
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of choline and inositol on 3H-dihydroalprenolol and 125I-iodocyanopindolol bindings to beta-adrenergic receptors of the guinea pig cerebral cortical membranes.
    Tsuchihashi H; Nagatomo T
    Chem Pharm Bull (Tokyo); 1988 Jan; 36(1):360-6. PubMed ID: 2837340
    [No Abstract]   [Full Text] [Related]  

  • 13. Characterization of beta-adrenergic receptors in the rat vas deferens using [3H]-dihydroalprenolol binding.
    Chang RS; Lotti VJ
    Life Sci; 1983 May; 32(22):2603-9. PubMed ID: 6134224
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of two putatively selective radioligands for labeling central nervous system beta-adrenergic receptors: inadequacy of [3H]dihydroalprenolol.
    Riva MA; Creese I
    Mol Pharmacol; 1989 Jul; 36(1):201-10. PubMed ID: 2546050
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Binding of (3H)dihydroalprenolol to beta adrenoceptors of cells isolated from adult rat heart.
    Moustafa E; Giachetti A; Downey HF; Bashour FA
    Naunyn Schmiedebergs Arch Pharmacol; 1978 May; 303(1):107-9. PubMed ID: 209345
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Binding of 3H-dihydroalprenolol to beta-adrenoceptors in adipocytes of spontaneously hypertensive rats and essentially hypertensive patients.
    Boriskina GM; Postnov YuV
    Experientia; 1982 Feb; 38(2):263-4. PubMed ID: 6277685
    [No Abstract]   [Full Text] [Related]  

  • 17. Increased number of beta-adrenergic receptors in the hypertrophied myocardium.
    Limas CJ
    Biochim Biophys Acta; 1979 Nov; 588(1):174-8. PubMed ID: 227473
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of polymeric effectors on binding of 3H-dihydroalprenolol to beta-adrenergic receptor of rat brain.
    Tsuchihashi H; Nagatomo T
    Jpn J Pharmacol; 1985 May; 38(1):17-23. PubMed ID: 2991640
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Displacement of [3H]dihydroalprenolol binding from rat heart and lung by acebutolol, diacetolol and D-diacetolol.
    Pong SF; Tinkham CL
    J Pharm Pharmacol; 1983 Mar; 35(3):198-9. PubMed ID: 6132987
    [No Abstract]   [Full Text] [Related]  

  • 20. Down regulation of dihydroalprenolol and imipramine binding sites in brain of rats repeatedly treated with imipramine.
    Kinnier WJ; Chuang DM; Costa E
    Eur J Pharmacol; 1980 Oct; 67(2-3):289-94. PubMed ID: 6257531
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.